HALO logo
halo search icon
CYP
Cynata Therapeutics Limited

CYP · Cynata Therapeutics Limited

0.02

AUD
-0.24 (-92.69%)
19/06/2026 03:59:36 PM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

AU$63.30M

PE

0.00

EV/EBITDA

N/A

DIV Yield

0%

Franking

0%

MQV Rating

5Very Weak

As at 19/06/2026 03:59:36 PM

Price Chart

Description

Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. It focuses on proprietary mesenchymal stem cell technology. Its products include CYP-001, CYP-004, and CYP-004. The company was founded on March 12, 2003 and is headquartered in Cremorne, Australia.

  • All-Companies
  • All-Consensus
  • GROWTH AUS
  • HALO Consensus Value
  • HALO Earnings Momentum
  • HALO Growth
  • HALO Momentum
  • HALO Ords
  • Volume Spike

Key Fundamentals

EPS 3 yr Growth

20.50%

EBITDA Margin

N/A

Operating Cashflow

-$9m

Free Cash Flow Return

-132.10%

ROIC

-142.30%

Interest Coverage

N/A

Quick Ratio

4.40

Performance

52 weeks range

Low 0.14 - 0.44

Trade Value (12mth)

AU$17,567.00

1 week

-13.33%

1 month

-24.64%

YTD

-26.76%

1 year

52.94%

All time high

4.60

Additional Data

Shares Outstanding (Fully Diluted)

234m

HALO Sector

Healthcare

Next Company Report Date

31-Aug-26

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

AUD

Short Sell (% of issue)

0.00

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

Halo Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Momentum

Price

Weak

Earnings

Very Strong

Growth

Earnings

Very Strong

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

DateEvent
19 June 26ASXD
19 June 26ASXD
17 June 26ASXD
16 June 26ASXD
12 June 26ASXD

See beyond the curve.

One solution for research, investing and portfolio management.
Want to learn more?Frequently asked questions.
1
What is the current share price of Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
The current share price of Cynata Therapeutics Limited (CYP:ASX) is AUD$0.02.
2
What is the 52-week high share price for Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
The 52-week high share price for Cynata Therapeutics Limited (CYP:ASX) is AUD$0.44.
3
What is the 52-week low share price for Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
The 52-week low share price for Cynata Therapeutics Limited (CYP:ASX) is AUD$0.14.
4
What is the dividend yield for Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
Cynata Therapeutics Limited (CYP:ASX) does not pay a dividend.
5
What was Cynata Therapeutics Limited (CYP:ASX) last dividend payment?
Halo FAQ
Cynata Therapeutics Limited (CYP:ASX) does not pay a dividend.
6
What is the franking level for Cynata Therapeutics Limited (CYP:ASX)?
Halo FAQ
Cynata Therapeutics Limited (CYP:ASX) has a franking level of 0.00%.
7
In which sector is Cynata Therapeutics Limited (CYP:ASX) classified?
Halo FAQ
Cynata Therapeutics Limited (CYP:ASX) is classified in the Healthcare.